Background illustration for clinical trials search

Paid Clinical Trials Raleigh

Discover 1,609 paid clinical trials in Raleigh, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study

for
Breast Cancer, Breast Neoplasms
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: Female

Age: 20 - 70+

Code: NCT07214610

Recruiting
Active & Responsive

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

for
CLL / SLL, CLL (Chronic Lymphocytic Leukemia),
Location: Chapel Hill NC, Columbus OH, Cincinnati OH,
Sponsor: Lomond Therapeutics Holdings, Inc.

Sex: All

Age: 18+

Code: NCT06708897

Phase1, Recruiting
Active & Responsive

Rifaximin for the Secondary Prevention of Recurrent Pouchitis

for
Pouchitis
Location: Chapel Hill NC, New York NY
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18 - 70+

Code: NCT06312683

Recruiting
Active & Responsive

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

for
Ulcerative Colitis
Location: Chapel Hill NC, Asheville NC, Chevy Chase MD,
Sponsor: Takeda

Sex: All

Age: 18 - 65

Code: NCT06095128

Recruiting
Active & Responsive

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

for
Myasthenia Gravis, Myasthenia Gravis, MuSK
Location: Chapel Hill NC, Augusta GA, Columbus OH, Tampa FL,
Sponsor: NMD Pharma A/S

Sex: All

Age: 18+

Code: NCT06414954

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Chapel Hill NC, Baltimore MD, Philadelphia PA,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase2, Recruiting
Active & Responsive

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

for
Eosinophilic Gastrointestinal Disorders (EGIDs),
Location: Chapel Hill NC, Bethesda MD, Philadelphia PA,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 3+

Code: NCT02523118

Recruiting
Active & Responsive

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

for
Inflammatory Bowel Disease (IBD), Crohn's Disease,
Location: Chapel Hill NC, New York NY
Sponsor: Mercy Medical Center

Sex: All

Age: 18+

Code: NCT06750731

Recruiting
Active & Responsive

Graded Exposure and Mindfulness Meditation for Patients Post-ACL Reconstruction

for
Anterior Cruciate Ligament Injuries
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 14 - 35

Code: NCT05949177

Recruiting
Active & Responsive

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

for
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Location: Chapel Hill NC, Atlanta GA, Jacksonville FL,
Sponsor: C4 Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07284758

Phase2, Recruiting
Active & Responsive

Impacts of Sugar Warnings on Weight Bias

for
Nutrition, Diet Interventions
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill

Sex: All

Age: 18+

Code: NCT07346001

Recruiting
Active & Responsive

Efficacy of Tezepelumab in Peanut Oral Immunotherapy

for
Peanut Allergy
Location: Chapel Hill NC, Baltimore MD, Cincinnati OH,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 12 - 55

Code: NCT07015996

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for
Crohn's Disease
Location: Chapel Hill NC, Charlotte NC, Richmond VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16 - 70+

Code: NCT06430801

Phase3, Recruiting
Active & Responsive

Gastroschisis Outcomes of Delivery (GOOD) Study

for
Gastroschisis
Location: Chapel Hill NC, Charlottesville VA, Baltimore MD,
Sponsor: Medical College of Wisconsin

Sex: Female

Age: 18+

Code: NCT02774746

Recruiting
Active & Responsive

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

for
Generalized Myasthenia Gravis
Location: Chapel Hill NC, Winston-Salem NC, Charleston SC,
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

Sex: All

Age: 18+

Code: NCT06463587

Phase3, Recruiting
Active & Responsive

Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings

for
Suicide, Attempted, Suicide Ideation, Suicide,
Location: Chapel Hill NC, Baltimore MD, Philadelphia PA,
Sponsor: Johns Hopkins University

Sex: All

Age: 12 - 24

Code: NCT06151158

Recruiting
Active & Responsive

Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Surgery Improvement Collaborative

for
Stone, Kidney, Stone Ureter
Location: Chapel Hill NC, New York NY, Brooklyn NY,
Sponsor: University of Michigan

Sex: All

Age: 18+

Code: NCT05866081

Recruiting
Active & Responsive

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

for
Primary Biliary Cholangitis
Location: Chapel Hill NC, Richmond VA, Charleston SC,
Sponsor: Ipsen

Sex: All

Age: 0+

Code: NCT06447168

Recruiting
Active & Responsive

A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

for
Human Immunodeficiency Virus (HIV),
Location: Chapel Hill NC, Greensboro NC, Columbia SC,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 16+

Code: NCT07044297

Phase3, Recruiting
Active & Responsive

Belimumab With Rituximab for Primary Membranous Nephropathy

for
Membranous Nephropathy, Nephrotic Syndrome
Location: Chapel Hill NC, Bethesda MD, Baltimore MD,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT03949855

Phase2, Recruiting